Advertisement

Topics

Lilly Pulitzer Company Profile

07:05 EST 20th November 2017 | BioPortfolio


News Articles [554 Associated News Articles listed on BioPortfolio]

Drugmaker Lilly beats Street 2Q forecasts, raises outlook

This Tuesday, July 17, 2012, file photo shows the Eli Lilly corporate headquarters in Indianapolis. Eli Lilly and Co.

Eli Lilly Pledges $52M to Life Sciences Partnership with Purdue

Injectable medications rank among Eli Lilly’s top-selling products. The Indianapolis drug giant is now scouting for new innovations in injectable medicine and it hopes to find them in its backyard. ...

Financial Comparison: Eli Lilly and (LLY) and Its Rivals

Eli Lilly and is one of 116 publicly-traded companies in the "Pharmaceuticals" industry, but how does it weigh in compared to its rivals? We will compare Eli Lilly and to similar companies based on th...

Eli Lilly: The Issues With Drug Development and Regaining the Public's Trust

In this episode of PharmaTelevision News Review, Paul Larsmon talks with Gino Santini, Vice President, Corporate Strategy, at Eli Lilly. Filmed at BIO-Europe 2009, they discuss: • Eli Lilly's CEO's ...

Lilly Announces Plans to Close its Shanghai R&D Center

In a letter to China employees, Andrew Hodge, President, Lilly China, notified staff members that Lilly will close down its Shanghai R&D center. The center opened in 2012 and is located in Zhangji...

Evonik, Lilly renew APIs & intermediates supply agreement

Evonik Industries and Eli Lilly and Company (Lilly) announced the renewal of a long─term agreement under which Evonik will supply active pharmaceutical ingredients (APIs) and intermediates for use i...

Produktions-Dienstleistung: Evonik und Lilly verlängern Liefervertrag für API

"Die Verlängerung dieser Liefervereinbarung belegt die hervorragende Zusammenarbeit von Evonik und Lilly. Wir danken Lilly für seine Weitsicht, 2010 eine gut gepflegte Anlage an Evonik zu übergeben...

Lilly Migraine Drug Demonstrates Long-Term Safety Results in Study

NewsIHC 2017: Lilly's galcanezumab demonstrates positive long-term safety results for up to 12 months in patients with migraine. Lilly plans to submit a BLA to the FDA by year end followed by submissi...

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Xigris [Eli Lilly and Company]

These highlights do not include all the information needed to use XIGRIS safely and effectively. See full prescribing information for XIGRIS.XIGRIS (drotrecogin alfa (activated)) injection, powder, ly...

Axid ar [Wyeth Consumer Healthcare]

Axid AR (nizatidine)

Gemzar [Eli Lilly and Company ]

These highlights do not include all the information needed to use GEMZAR safely and effectively. See full prescribing information for GEMZAR.GEMZAR (gemcitabine for injection) Powder, Lyophilized, For...

Humulin [Eli Lilly and Company]

HUMULIN 70/3070% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (rDNA ORIGIN)100 UNITS PER ML (U-100)

Humulin [Eli Lilly and Company]

HUMULIN N NPH HUMAN INSULIN (rDNA ORIGIN)ISOPHANE SUSPENSION100 UNITS PER ML (U-100)

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Abemaciclib: First Global Approval.

Abemaciclib (Verzenio™) is an orally administered inhibitor of cyclin-dependent kinases 4 and 6 that is being developed by Eli Lilly and Company. Abemaciclib has been approved in the USA for the tre...

Virtual screening and repositioning of inconclusive molecules of beta-lactamase Bioassays-A data mining approach.

This study focuses on the best possible way forward in utilizing inconclusive molecules of PubChem bioassays AID 1332, AID 434987 and AID 434955, which are related to beta-lactamase inhibitors of Myco...

The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine.

In the past decade, the federal government has frequently investigated and prosecuted pharmaceutical manufacturers for illegal promotion of drugs for indications not approved by the Food and Drug Admi...

Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR(®)/ABASAGLAR(®)) approved in the European Union.

Basaglar(®)/Abasaglar(®) (Lilly insulin glargine [LY IGlar]) is a long-acting human insulin analogue drug product granted marketing authorisation as a biosimilar to Lantus(®) (Sanofi insulin glargi...

A Comparative Pharmacokinetic Study of 2 Pemetrexed Formulations in Indian Adult Chemonaive Patients With Adenocarcinoma Stage III/IV Non-Small Cell Lung Cancer.

The study aimed to compare the pharmacokinetics of 2 pemetrexed formulations (Pemgem, Dr. Reddy's Laboratories w.r.t; Alimta, Eli Lilly) in adult chemonaive subjects with adenocarcinoma stage III/IV n...

Clinical Trials [22 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

This is a blinded, randomized crossover study to compare the safety and efficacy of G-Pen™ (glucagon injection) to Lilly Glucagon (glucagon for injection [rDNA origin]) for hypoglycemia ...

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the ATU.

Lilly's Emotional and Physical Symptoms of Depression

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

Lilly's Emotional and Physical Symptoms of Depression Study

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice-based setting

Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

Companies [56 Associated Companies listed on BioPortfolio]

Lilly Pulitzer

Lilly USA

Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and fro...

Lilly Corporate Center

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. ...

Applied Molecular Evolution

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME...

Eli Lilly and Company

<!--LGfEGNT2Lhm-->Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that...

More Information about "Lilly Pulitzer" on BioPortfolio

We have published hundreds of Lilly Pulitzer news stories on BioPortfolio along with dozens of Lilly Pulitzer Clinical Trials and PubMed Articles about Lilly Pulitzer for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lilly Pulitzer Companies in our database. You can also find out about relevant Lilly Pulitzer Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record